Introduction
============

Keratoconus (KC; Mendelian Inheritance in Man \[MIM\] 14830) is a rare disease characterized by thinning of the corneal stroma, resulting in reduced vision, irregular astigmatism and corneal scarring. The age of onset is mostly at puberty with the estimated prevalence of KC is 1--4 in 2000 in general population. Exact cause of KC is still unclear, although pathogenesis may involve genetic \[[@r1],[@r2]\], environmental and behavioral factors \[[@r3],[@r4]\]. KC is one of the most common cause for corneal transplantation. Inheritance of KC does not usually follow a simple Mendelian inheritance in majority of cases and appears to be sporadic \[[@r5]\], but positive family history is reported in 6% to 10% of patients \[[@r6]\]. Both recessive and dominant pattern of inheritance have been reported with predominance of autosomal dominant inheritance and disease shows incomplete penetrance and variable expressivity \[[@r7],[@r8]\]. Since, cornea is an avascular structure and first target of ultraviolet radiation entering the eyes, it is potentially vulnerable to oxidative stress \[[@r9]\]. Studies report the role of oxidative damage in KC and other corneal diseases \[[@r10],[@r11]\].

In a previous study from our laboratory we have reported association of mtDNA variations with congenital glaucoma \[[@r12]\]. We have shown the presence of mtDNA complex I sequence variations which were associated with elevated ROS production in congenital glaucoma. In this pilot study we reported the results of mitochondrial complex I gene analysis in 20 keratoconus patients negative for Visual System Homeobox 1 (*VSX1*) mutations \[[@r13]\].

Methods
=======

Ethics statement
----------------

All patients provided informed consent before participation in this study. The study was approved by Institutional Review Board (IRB00006862; All India Institute of Medical Sciences, New Delhi, India).

Clinical examination and selection of cases
-------------------------------------------

A total of twenty keratoconus patients ([Table 1](#t1){ref-type="table"}) presented (during April 2009 to April 2010) at the Dr. R. P. Centre for Ophthalmic Sciences (AIIMS, New Delhi, India) were enrolled in this study. Clinical evaluation involved Ultrasonic Pachymetry, videokeratography (VKG), Orbscan, visual testing, fundoscopy, slitlamp-biomicroscopy, and retinoscopy. Of these patients, 14 were males and 6 were females. The mean age of presentation was 17.2 years. Diagnosis of keratoconus involved the presence of characteristic topographic features, such as inferior or central corneal steepening, or an asymmetric bowtie pattern with skewing of the radial axes, and the presence of one or more of the following characteristic, clinical features in one or both eyes: conical corneal deformation, munsen sign, corneal stromal thinning, a Fleischer ring or Vogt striae. Family history up to three generations was collected and pedigrees were drawn. All 20 cases were sporadic without any family history. All keratoconus cases secondary to causes like trauma, surgery, Ehlers Danlos syndrome, osteogenesis imperfecta, and pellucid marginal degeneration were excluded from the study. Twenty ethnically matched normal individuals without any ocular disorder were enrolled as controls. Health information was obtained from controls through the questionnaire; all underwent ophthalmological examination. Five milliliters of blood was collected by venipuncture in EDTA (EDTA) vaccutainers (Greiner Bio-One GmbH, Frickenhausen, Germany) from both patients and controls. DNA was extracted from whole blood samples by the inorganic method. For the population study, controls were taken from published data defining the lineage of the Indian population \[[@r14],[@r15]\].

###### Clinical phenotype of keratoconus patients.

  **Patient ID**   **Age in years**   **Sex**   **Visual acuity in Snellen's chart**   **Munsen sign**   **Vogt\'s striae**   **Hydrops**   **Scarring**   **Keratometry in VKG (in diopters)**   **Ultrasonic pachymetry (in micrometers)**                                                
  ---------------- ------------------ --------- -------------------------------------- ----------------- -------------------- ------------- -------------- -------------------------------------- -------------------------------------------- ---- ---- ---- ----------- ----------- ----- -----
  KC1              20                 F         6/12                                   6/12              \+                   \+            \-             \-                                     \-                                           \-   \-   \-   45.62       46.37       490   414
  KC2              12                 M         6/60                                   6/60              \+                   \+            \+             \+                                     \+                                           \+   \+   \+   56          52          344   347
  KC3              22                 F         6/12                                   6/6               \+                   \+            \+             \+                                     \+                                           \-   \+   \-   56.6        49.5        396   412
  KC4              20                 M         6/12                                   6/9               \+                   \+            \+             \+                                     \+                                           \-   \+   \-   48.5        45          406   498
  KC5              20                 M         6/24                                   6/6               \+                   \-            \+             \-                                     \+                                           \-   \+   \-   54          46.5        410   520
  KC6              19                 M         6/12                                   6/12              \+                   \+            \+             \+                                     \-                                           \-   \-   \-   46.5        46.5        501   488
  KC7              18                 M         618                                    6/60              \+                   \+            \+             \+                                     \-                                           \+   \-   \+   52.12       Distorted   480   344
  KC8              14                 F         6/36                                   6/24              \+                   \+            \+             \+                                     \+                                           \+   \+   \+   \>52        52          336   346
  KC9              20                 M         6/9                                    6/9               \+                   \+            \+             \+                                     \-                                           \-   \-   \-   50.5        49.1        460   436
  KC10             22                 M         6/24                                   6/9               \+                   \-            \+             \-                                     \-                                           \-   \-   \-   52          47.1        344   420
  KC11             19                 M         6/18                                   6/18              \+                   \+            \+             \+                                     \+                                           \+   \+   \-   54.75       56          410   400
  KC12             17                 M         6/12                                   6/18              \+                   \+            \+             \+                                     \-                                           \-   \-   \-   51.12       49.87       419   414
  KC13             20                 F         6/9                                    6/12              \+                   \+            \+             \+                                     \-                                           \-   \-   \-   48.5        51.25       440   456
  KC14             10                 M         6/12                                   6/9               \+                   \+            \+             \-                                     \+                                           \-   \+   \-   61.12       48.75       402   512
  KC15             22                 F         6/12                                   6/12              \+                   \+            \-             \+                                     \-                                           \-   \+   \+   48.5        48          502   486
  KC16             18                 F         6/6                                    6/60              \-                   \-            \-             \+                                     \-                                           \+   \-   \+   Distorted   49.5        510   265
  KC17             22                 M         6/6                                    6/9               \+                   \+            \+             \+                                     \-                                           \-   \-   \-   49.5        51.75       399   353
  KC18             15                 M         6/9                                    6/18              \+                   \+            \+             \+                                     \+                                           \-   \-   \-   48.25       48.75       485   493
  KC19             20                 F         6/60                                   6/60              \+                   \+            \+             \+                                     \+                                           \+   \+   \+   Distorted   Distorted   230   330
  KC20             16                 M         6/12                                   6/9               \+                   \+            \+             \+                                     \-                                           \-   \-   \-   48          48.25       484   496

Key: M=male; F=female; OD=right eye; OS=left eye; +=positive; -=negative; VKG=videokeratography.

Polymerase chain reaction (PCR) amplification and sequence analysis of the mitochondrial DNA coding region
----------------------------------------------------------------------------------------------------------

The mitochondrial complex 1 (*ND1*, *ND2*, *ND3*, *ND4*, *ND4L*, *ND5*, and *ND6* \[ND stands for NADH dehydrogenase\]) was amplified in all patients and controls using 12 pairs of primers using cycling conditions as described by Kumar and associates \[[@r16]\] and presented in [Table 2](#t2){ref-type="table"}. Briefly, PCR amplifications for all primer sets were performed in a 40-μl volume containing 1.0 μl of 20 μM stock solution for each primer (Eurofins Genomics India pvt Ltd, Bangalore, India), 100 ng of genomic DNA, 1 unit of Taq polymerase (Banglore Genei, Bengaluru, Karnataka, India), 0.1 mM of each deoxynucleotide triphosphate (dNTP), and 4 μl of 10× PCR buffer (with 15 mM MgCl~2~) by means of 30 cycles of amplification, each consisting of 30 s denaturation at 94 °C, 30 s annealing at 55 °C, and 1 min extension at 72 °C. Finally, an extension for 5 min at 72 °C was performed. Amplified PCR products were purified using a gel/PCR DNA fragments extraction kit (catalog number DF100; Geneaid Biotech Ltd., Sijhih City, Taiwan). Purified PCR products of both primers (forward and reverse) were sent for sequencing to MCLAB (Molecular Cloning Laboratories, South San Francisco, CA). All sequence variants from both KC patients and controls were compared to the Human Mitochondrial reference sequence [NC_012920](http://www.ncbi.nlm.nih.gov/nuccore/NC_012920?log$=ACCN)) provided by the National Center for Biotechnology Information ([NCBI](http://www.ncbi.nlm.nih.gov/)) using [ClustalW2](http://www.ebi.ac.uk/Tools/msa/clustalw2/) (multiple sequence alignment program for DNA; European Molecular Biology Laboratory ([EMBL](http://www.ebi.ac.uk/embl/))-European Bioinformatics Institute (EBI).

###### Primer used for amplification of complex-I gene of mitochondria.

  **Primer name**   **Primer sequence**             **Product size**   **Melting temperature (°C)**
  ----------------- ------------------------------- ------------------ ------------------------------
  1                 F-3'GGACTAACCCCTATACCTTCTGC5'                        
                    R-3'GGCAGGTCAATTTCACTGGT5'      859                55
  2                 F-3'AAATCTTACCCCGCCTGTTT5'                           
                    R-3'AGGAATGCCATTGCGATTAG5'      885                55
  3                 F-3'TACTTCACAAAGCGCCTTCC5'                           
                    R-3'ATGAAGAATAGGGCGAAGGG5'      831                55
  4                 F-3'TGGCTCCTTTAACCTCTCCA5'                           
                    R-3'AAGGATTATGGATGCGGTTG5'      903                55
  5                 F-3'ACTAATTAATCCCCTGGCCC5'                           
                    R-3'CCTGGGGTGGGTTTTGTATG5'      978                55
  6                 F-3'TCTCCATCTATTGATGAGGGTCT5'                        
                    R-3'AATTAGGCTGTGGGTGGTTG5'      892                55
  7                 F-3'GCCATACTAGTCTTTGCCGC5'                           
                    R-3'TTGAGAATGAGTGTGAGGCG5'      859                55
  8                 F-3'TCACTCTCACTGCCCAAGAA5'                           
                    R-3'GGAGAATGGGGGATAGGTGT5'      801                55
  9                 F-3'TATCACTCTCCTACTTACAG5'                           
                    R-3'AGAAGGATATAATTCCTACG5'      865                55
  10                F-3'AAACAACCCAGCTCTCCCTAA5'                          
                    R-3'TCGATGATGTGGTCTTTGGA5'      976                55
  11                F-3'ACATCTGTACCCACGCCTTC5'                           
                    R-3'AGAGGGGTCAGGGTTGATTC5'      969                55
  12                F-3'GCATAATTAAACTTTACTTC5'                           
                    R-3'AGAATATTGAGGCGCCATTG5'      937                55

Computational assessment of missense mutations
----------------------------------------------

For prediction of pathogenic characteristics of all non-synonymous mtDNA changes two homology based programs [PolyPhen-2](http://genetics.bwh.harvard.edu/pph2/) (Polymorphism Phenotyping) and [SIFT](http://sift.jcvi.org/) (Sorting Intolerant From Tolerant) were used.

PolyPhen structurally analyzes an amino acid polymorphism and predicts whether that amino acid change is likely to be deleterious to protein function \[[@r17]-[@r19]\]. [Polyphen-2](http://genetics.bwh.harvard.edu/pph2/) is more advanced version of the earlier version PolyPhen \[[@r20]\]. The prediction is based on the position-specific independent counts (PSIC) score derived from multiple sequence alignments of observations in case of functional domain of protein and predicted hydrophobic and transmembrane (PHAT) matrix element difference in case of transmembrane region of protein. PolyPhen scores of above 0.85 indicate the polymorphism is probably damaging to protein function. Scores of above 0.15 are possibly damaging, and scores of less than 0.15 are classified as benign.

[SIFT](http://sift.jcvi.org/) is a sequence homology-based tool that sorts intolerant from tolerant amino acid substitutions and predicts whether an amino acid substitution in a protein will have a phenotypic effect \[[@r21]-[@r23]\]. [SIFT](http://sift.jcvi.org/) is based on the premise that protein evolution is correlated with protein function. Positions important for function should be conserved in an alignment of the protein family, whereas unimportant positions should appear diverse in an alignment. Positions with normalized probabilities less than 0.05 are predicted to be deleterious and, those greater than or equal to 0.05 are predicted to be tolerated.

Haplogroup and phylogenetic analysis
------------------------------------

To check the fidelity of our conclusion, the evolutionary information and the significance of mutations should be known. For haplogroups (Hg) analysis we have carefully chosen two hundred healthy individual samples from same area for comparison analysis and these were also treated as controls. For all control samples, sequences of the control region were determined from position 16024 to 00300, using the ABI Prism Dye Terminator cycle-sequencing protocols developed by Applied Biosystems (Perkin-Elmer, Foster City, CA), to provide an initial presumed Hg assignment and cases were haplogrouped by complete coding region sequences. The C-track length variation at positions 16182 and 16183 in HVS-I and the indels at positions 00309 and 00315 in HVS-II were excluded from further analyses. Hg assignment was then confirmed, based on control and coding region Hg defining polymorphisms determined by means of direct sequencing.

The NETWORK 4.5.1.6 program was run for placing all the mutations of control samples in their respective phylogenetic tree using the protocol as described at the [Fluxus Engineering Website](http://www.fluxus-engineering.com/). The matrilineal lineages of the case were drawn manually in the reduced median network of control samples, to create the topology map we have applied the reduced median algorithm (r=1), followed by the median-joining algorithm (epsilon=2).

Principal component analysis
----------------------------

To minimize errors both strands were double-sequenced. Principal component analysis (PCA) of mtDNA was performed. For this experiment we compiled our data of mitochondrial haplogroups. Controls samples of five different populations were taken from published data defining Indian lineage for comparative analysis representing each sector of India i.e., Northern India, North-Western India, Western India, Eastern India, and Southern India.

The [MVSP](http://www.kovcomp.co.uk/mvsp/index.html) software package (Kovach WL, Services KC. MVSP - A multi-variate statistical package for Windows ver 3.13m. 2004) was used to identify the principal components (PCs) of mitochondrial variations that lead to form a haplogroup for every individual. To express the relative importance of top two eigenvectors in the resulting PCA plot, two axes were scaled by a factor equal to the square root of the corresponding eigen value. This experiment was repeated to confirm the outcomes.

Results
=======

Sequence variation in Complex I genes
-------------------------------------

DNA sequencing of Complex I genes revealed a total 84 nucleotide variation in patients ([Table 3](#t3){ref-type="table"}) and 29 variations in controls ([Table 4](#t4){ref-type="table"}). Of the 84 nucleotide variations in patients, 18 (21.42%) were non synonymous ([Table 5](#t5){ref-type="table"}), 52 (61.90%) were synonymous, 9 (10.71%) variations were in RNA genes and 3 (3.57%) were in non-coding region. Of 84 nucleotide variations in KC patients; five variations (3918G\>A, 5348C\>T, 12007G\>A, 12372G\>A and 12561G\>A) were also present in controls. Out of 29 nucleotide variations found in controls 5 were non-synonymous. Maximum nucleotide variations were in *ND5* (n=28) followed by *ND4* (n=15); *ND2* (n=13); *ND3* (n=7); *ND1* (n=3); *ND4L* (n=3), tRNAs (n=9), rRNAs (n=2) and 3 in non-coding regions.

###### Complex 1variations observed in KC patients.

  **Sample number**   **Genomic position**   **Base change**   **Gene/ location**   **Amino acid position**   **Codon change**   **Amino acid change**   **Change in protein**   **Total no. of patients with nt changes**   **GeneBank accession number if novel**
  ------------------- ---------------------- ----------------- -------------------- ------------------------- ------------------ ----------------------- ----------------------- ------------------------------------------- ----------------------------------------
  1                   2706                   G\>A              16rRNA                                                                                                            1                                            
  2                   2887                   T\>C              16rRNA                                                                                                            1                                            
  3                   3918                   G\>A              ND1                  204                       GAG\>GAA           Glu\>Glu                p.E204E                 1                                            
  4                   3921                   T\>C              ND1                  205                       TCT\>TCT           Ser\>Ser                p.S205S                 1                                            
  5                   4216                   T\>C              ND1                  304                       TAT\>CAT           Tyr\>His                p.Y304H                 3                                            
  6                   4454                   T\>C              tRNA met                                                                                                          1                                            
  7                   4682                   C\>A              ND2                  71                        CTA\>ATA           Leu\>Ile                p.L71I                  1                                           Yes
  8                   4688                   T\>C              ND2                  73                        GCT\>GCC           Ala\>Ala                p.A73A                  1                                            
  9                   4696                   T\>C              ND2                  76                        TTC\>TCC           Phe\>Ser                p.F76S                  1                                           Yes
  10                  4715                   A\>G              ND2                  100                       ATG\>ATA           Met\>Met                p.M100M                 1                                            
  11                  4833                   A\>G              ND2                  122                       ACC\>GCC           Thr\>Ala                p.T122A                 1                                            
  12                  4917                   A\>G              ND2                  150                       AAC\>GAC           Asn\>Asp                p.N150D                 1                                            
  13                  5046                   G\>A              ND2                  193                       GTT\>ATT           Val\>Ile                p.V193I                 1                                            
  14                  5108                   T\>C              ND2                  213                       ACT\>ACC           Thr\>Thr                p.T213T                 1                                            
  15                  5300                   T\>T, Del CA      ND2                  277                       Frame shift        p.Ile277His fs X11      p.I287X                 1                                           Yes
  16                  5348                   C\>T              ND2                  293                       TAT\>TAC           Tyr\>Tyr                p.Y293Y                 1                                            
  17                  5351                   A\>G              ND2                  294                       TTA\>TTG           Leu\>Leu                p.L294L                 1                                            
  18                  5360                   C\>T              ND2                  297                       ATC\>ATT           Ile\>Ile                p.I297I                 1                                            
  19                  5460                   G\>A              ND2                  331                       GCC\>ACC           Ala\>Thr                p.A331T                 1                                            
  20                  5580                   C\>T              NC                                                                                                                20                                           
  21                  5585                   G\>A              NC                                                                                                                20                                           
  22                  5601                   C\>T              tRNA Ala                                                                                                          2                                            
  23                  5790                   C\>A              OL                                                                                                                1                                            
  24                  5899                   InsC              NC                                                                                                                1                                           Yes
  25                  5900                   InsC              NC                                                                                                                                                            Yes
  26                  10084                  T\>C              ND3                  9                         ATC\>ACC           Ile\>Thr                p.I9T                   1                                            
  27                  10142                  C\>T              ND3                  18                        AAC\>AAT           Asn\>Asn                p.N18N                  1                                            
  28                  10253                  T\>C              ND3                  65                        TTT\>TTC           Phe\>Phe                p.F65F                  1                                            
  29                  10304                  T\>C              ND3                  82                        ACT\>ACC           Thr\>Thr                p.T82T                  1                                           Yes
  30                  10373                  G\>A              ND3                  105                       GAG\>GAA           Glu\>Glu                p.E105E                 1                                            
  31                  10398                  G-A               ND3                  114                       GCC-ACC            Ala\>Thr                p\. A 114 T             8                                            
  32                  10400                  C-T               ND3                  114                       GCC-GCT            Ala-Ala                 p\. A114 A              9                                            
  33                  10411                  A\>G              tRNA Arg                                                                                                                                                       
  34                  10463                  T\>C              tRNA Arg                                                                                                          1                                            
  35                  10685                  G\>A              ND4L                 72                                           Ala\>Ala                p.A72A                  1                                            
  36                  10631                  C\>T              ND4L                 54                                           Leu\>Leu                p.L54L                  1                                            
  38                  10819                  A\>G              ND4                  20                        CTG\>CTA           Lys-Lys                 p.K20K                  20                                           
  39                  10873                  C-T               ND 4                 38                        CCC-CCT            Pro-Pro                 P38P                    20                                           
  40                  10951                  C\>T              ND4                  64                        CCC\>CCT           Pro\>Pro                p.P64P                  1                                           Yes
  41                  11017                  C-T               ND 4                 86                        AGC-AGT            Ser-Ser                 S86S                    20                                           
  42                  11251                  A\>G              ND4                  164                       CTA\>CTG           Leu\>Leu                p.L164L                 1                                            
  43                  11273                  G\>C, Del G       ND4                  172                       Frame shift        p.gly172AlafsX2         p.L174X                 1                                           Yes
  44                  11437                  T\>C              ND4                  226                       GCT\>GCC           Ala\>Ala                p.A226A                 1                                            
  45                  11467                  A\>G              ND4                  236                       TTA\>TTG           Leu\>Leu                p.L236L                 3                                            
  46                  11673                  C\>T              ND4                  305                       ACC\>ACT           Thr\>Thr                p.T305T                 1                                            
  47                  11722                  C\>T              ND4                  321                       CTC\>CTT           Leu\>leu                p.L305L                 20                                           
  48                  11902                  G\>C              ND4                  381                       GTG\>GTC           Val\>Val                p.V381V                 1                                            
  49                  11914                  G\>A              ND4                  385                       ACG\>ACA           Thr\>Thr                p.T385T                 1                                            
  50                  11947                  A\>G              ND4                  396                       ACA\>ACG           Thr\>Thr                p.T396T                 1                                            
  51                  11969                  G\>A              ND4                  404                       GCC\>ACC           Ala\>thr                p.A404T                 3                                            
  52                  12007                  G\>A              ND 4                 416                       TGG-TGA            Tryp-Tryp               p\. W416 W              9                                            
  53                  12234                  G\>A              tRNA Ser                                                                                                          1                                            
  54                  12236                  G\>A              tRNA Ser                                                                                                          1                                            
  55                  12330                  A\>G              tRNA Ser                                                                                                          3                                           Yes
  56                  12308                  A\>G              tRNA Leu                                                                                                          5                                            
  37                  12330                  A\>G              tRNA Leu                                                                                                                                                       
  57                  12361                  A\>G              ND5                  9                         ACC\>AAA           Thr\>Ala                p.T9A                   1                                            
  58                  12372                  G\>A              ND5                  12                        CTG\>CTA           Leu\>Leu                p.L12L                  5                                            
  59                  12414                  T\>C              ND5                  26                        CCT\>CCC           Pro\>Pro                p.P26P                  1                                            
  60                  12426                  C\>A              ND5                  30                        AAC\>AAA           Asp\>Lys                p.D30L                  1                                            
  61                  12561                  G\>A              ND5                  75                        CAG\>CAA           Gln\>Gln                p.Q75Q                  1                                            
  62                  12633                  C\>A              ND5                  99                        TCC\>TCA           Ser\>Ser                p.S99S                  2                                            
  63                  12624                  T\>C              ND5                  96                        GTT\>GTC           Val\>Val                p.V96V                  1                                            
  64                  12672                  A\>G              ND5                  112                       CCA\>CCG           Pro\>Pro                p.P112P                 2                                            
  65                  12654                  A\>G              ND5                  106                       TGA\>TGG           Trp\>Trp                p.W106W                 1                                           Yes
  66                  12705                  T-C               ND5                  123                       ATT-ATC            Ile-Ile                 p\. I 123 I             11                                           
  67                  12850                  G-A               ND 5                 172                       GTC-ATC            Val --Ile               p\. I 172 V             20                                           
  68                  12879                  G\>C              ND5                  181                       GGT\>GGC           Gly\>Gly                P.G181G                 1                                            
  69                  13065                  C\>T              ND5                  243                       GTC\>CTT           Val\>Val                p.V243V                 1                                            
  70                  13104                  A\>G              ND5                  256                       GGA\>GGG           Gly\>Gly                p.G256G                 1                                            
  71                  13174                  T\>C              ND5                  280                       TTA\>CTA           Leu\>Leu                p.L280L                 1                                            
  72                  13263                  A\>G              ND5                  309                       CAA\>CAG           Gln\>Gln                p.Q309Q                 1                                            
  73                  13368                  G\>A              ND5                  344                       GGG\>GGA           Gly\>Gly                p.G344G                 2                                           Yes
  74                  13434                  A\>G              ND5                  367                       ATA\>ATG           Met\>Met                p.M366M                 2                                            
  75                  13488                  T\>C              ND5                  384                       GGT\>GGC           Gly\>Gly                p.G384G                 1                                            
  76                  13500                  T\>C              ND5                  388                       GGT\>GGC           Pro\>Pro                p.P388P                 3                                            
  77                  13563                  A\>G              ND5                  409                       CTA\>CTG           Leu\>Leu                P.L409L                 4                                            
  78                  13557                  A\>G              ND5                  407                       TGA\>TGG           Trp\>Trp                p.W407W                 1                                           Yes
  79                  13617                  T\>G              ND5                  427                       ATT\>ATC           Ile\>Ile                p.I427I                 2                                            
  80                  13637                  A\>G              ND5                  434                       CAA\>CAG           Glu\>Arg                p.Q434R                 2                                            
  81                  13768                  T\>C              ND5                  478                       TTC\>ATC           Phe\>Ile                p.F479I                 3                                            
  82                  13914                  C\>A              ND5                  526                       CTC\>CTA           Leu\>Leu                p.L526L                 3                                            
  83                  14058                  C\>T              ND5                  574                       TCC\>TCT           Ser\>Ser                p.S574S                 1                                            
  84                  14070                  A\>G              ND5                  578                       TCA\>TCG           Ser\>Ser                p.S578S                 1                                            

Abbreviations: KC represents Keratoconus; nt- Nucleotides, A -- Adenine; T -- Thymine; G- Guanine; C- Cytosine; ND1 represents NADH dehydrogenase subunit 1, ND2 represents NADH dehydrogenase subunit 2; ND3- NADH dehydrogenase subunit 3; ND4- NADH dehydrogenase subunit 4; ND4L- NADH dehydrogenase subunit 4L; ND5- NADH dehydrogenase subunit 5.

###### Complex 1 variations observed in controls.

  **Sample number**   **Genomic position**   **Base change**   **Locus**   **Amino acid position**   **Codon change**   **Amino acid change**   **Change in protein**
  ------------------- ---------------------- ----------------- ----------- ------------------------- ------------------ ----------------------- -----------------------
  1                   3591                   G\>A              ND1         95                        CTG\>CTA           Thr\>Thr                p.T95T
  2                   3915                   G\>A              ND1         203                       GGG\>GGA           Gly\>Gly                p.G203G
  3                   3918                   G\>A              ND1         204                       GAG\>GAA           Glu\>Glu                p.E204E
  4                   3933                   A\>G              ND1         209                       TCA\>TCG           Ser\>Ser                p.S209S
  5                   3970                   C\>T              ND1         222                       CTA\>TTA           Leu\>Leu                p.L222L
  6                   3996                   C\>T              ND1         230                       AAC\>AAT           Asn\>Asn                p.N230N
  7                   4093                   A\>G              ND1         263                       ACC\>GCC           Thr\>Ala                p.T263A
  8                   4029                   C\>A              ND1         241                       ATC\>ATA           Ile\>Ile                p.I241I
  9                   4793                   A\>G              ND2         108                       ATA\>ATG           Met\>Met                p.M108M
  10                  4852                   T\>A              ND2         128                       CTG\>CAG           Leu\>Gln                p.L128Q
  11                  5186                   A\>T              ND2         239                       TGA\>TGT           Trp\>Cys                p.W239C
  12                  5348                   C\>T              ND2         293                       TAC\>TAT           Tyr\>Tyr                p.Y293Y
  13                  10310                  G\>A              ND3         84                        CTG\>CTA           Thr\>Thr                p.T84T
  14                  11467                  A\>G              ND4         236                       TTA\>TTG           Leu\>Leu                p.L236L
  15                  11914                  G\>A              ND4         385                       ACG\>ACA           Thr\>Thr                p.T385T
  16                  12007                  G\>A              ND4         416                       TGG\>TGA           Trp\>Trp                p.W416W
  17                  12073                  C\>T              ND4         438                       TTC\>TTT           Phe\>Phe                p.F438F
  18                  12107                  C\>T              ND4         449                       CTC\>CTT           Thr\>Thr                p.T449T
  19                  12133                  C\>T              ND4         458                       TCC\>TCT           Ser\>Ser                p.S458S
  20                  13299                  A\>G              ND5         321                       CAA\>CAG           Gln\>Gln                p.Q321Q
  21                  12372                  G\>A              ND5         12                        CTG\>CTA           Tyr\>Tyr                p.T12T
  22                  12373                  A\>G              ND5         13                        ACT\>GCT           Thr\>Ala                p.T13A
  23                  12406                  G\>A              ND5         24                        GTT\>ATT           Val\>Ile                p.V24I
  24                  12486                  C\>T              ND5         50                        CCC\>CCT           Pro\>Pro                p.P50P
  25                  12498                  C\>T              ND5         54                        TTC\>TTT           Phe\>Phe                p.F54F
  26                  12561                  G\>A              ND5         75                        CAG\>CAA           Gln\>Gln                p.Q75Q
  27                  13731                  A\>G              ND5         465                       GGA\>GGG           Gly\>Gly                p.G465G
  28                  13806                  C\>T              ND5         490                       GCC\>GCT           Ala\>Ala                p.A490A
  29                  14058                  C\>T              ND5         574                       TCC\>TCT           Ser\>Ser                p.S574S

Abbreviations: A -- Adenine; T -- Thymine; G- Guanine; C- Cytosine; ND1 represents NADH dehydrogenase subunit 1, ND2 represents NADH dehydrogenase subunit 2;ND3- NADH dehydrogenase subunit 3; ND4-NADH dehydrogenase subunit 4; ND5- NADH dehydrogenase subunit 5.

###### Mitochondrial DNA sequence variations (non-synonymous) detected in KC patients.

  **Sample number**   **Nucleotide substitution**   **Amino acid change**   **Change in protein**   **SIFT score**   **SIFT prediction**   **Polyphen score**
  ------------------- ----------------------------- ----------------------- ----------------------- ---------------- --------------------- --------------------
  2                   4216T\>C                      Tyr\>His                p.Y304H                 0.82             Tolerant              0.008
  3                   4917 A\>G                     Asn\>Asp                p.N150D                 0.14             Tolerant              0.006
  4                   5046 G\>A                     Val\>Ile                p.V193I                 0.61             Tolerant              0.000
  5                   4833 A\>G                     Thr\>Ala                p.T122A                 0.10             Tolerant              0.135
  6                   4682 C\>A                     Leu\>Ile                p.L71I                  0.01             Pathogenic            0.001
  7                   4696 T\>C                     Phe\>Ser                p.F76S                  0.14             Tolerant              0.000
  8                   5300T\>T                      p.Ile277His fs X11      p.I287X                                                         
  9                   5460 G\>A                     Ala\>Thr                p.A331T                 0.37             Tolerant              0.000
  10                  10084T\>C                     Ile\>Thr                p.I9T                   0.49             Tolerant              0.000
  11                  10398 G-A                     Ala\>Thr                p\. A 114 T             1.00             Tolerant              0.000
  12                  11273G\>C                     p.gly172AlafsX2         p.L174X                                                         
  13                  11969G\>A                     Ala\>Thr                p.A404T                 0.13             Tolerant              0.000
  14                  12361A\>G                     Thr\>Ala                p.T9A                   0.00             Pathogenic            Not available
  15                  12426C\>A                     Asn\>Lys                p.N30L                  0.21             Tolerant              0.899
  16                  12850G\>A                     Val \>Ile               p\. I172V               1.00             Tolerant              0.422
  17                  13637A\>G                     Glu\>Arg                p.Q434R                 0.41             Tolerant              0.008
  18                  13768T\>C                     Phe\>Ile                p.F478I                 0.17             Tolerant              0.005

Of 84 variations, 2 variations were frame-shift (11273G\>A, 5300T\>T). In one patient (KC 16) a single base deletion of guanine was observed at mtDNA position 11273. This caused a frame shift mutation after codon 172 (Gly\>Ala) and introduced a stop codon at position 174 which resulted in a 173 amino acids truncated protein.This variation was homoplasmic ([Figure 1](#f1){ref-type="fig"}).

![Mt DNA sequence chromatogram of *ND4* gene. **A**: The reference sequence derived from control is shown. **B**: Sequence derived from keratoconus patient K16 shows a deletion of G at11273, which cause a codon change GGC\>GCT and p.gly172AlafsX2 (p.L174X) mutation.](mv-v17-1514-f1){#f1}

In patient KC 2, we found a 2 base pair (CA) deletion at genomic position 5300 and 5301. This frame shift mutation altered the amino acid reading frame in ND2 protein at position 277. This CA deletion produced a truncated protein of 287 amino acids ([Figure 2](#f2){ref-type="fig"}).

![Mt DNA sequence chromatogram of *ND2* CA Deletion. **A**: The reference sequence derived from control is shown. **B**: Sequence derived from keratoconus patient K2 shows two base deletion CA at 5300, which causes a codon change ATC\>ATT and p.Ile277His fsX11(p.I287X) mutation.](mv-v17-1514-f2){#f2}

In silico analysis
------------------

[SIFT](http://sift.jcvi.org/) analysis revealed two pathogenic changes (p.L71I and p.T9A) and [PolyPhen](http://genetics.bwh.harvard.edu/pph2/) revealed two pathogenic changes (p.N30L and p.I172V). The polyphen score of p.T9A was not available (no result for this mutation was available through [PolyPhen](http://genetics.bwh.harvard.edu/pph2/); [Table 5](#t5){ref-type="table"}).

Principle component analysis
----------------------------

The tight cluster in Principal component Analysis (PCA) plot comprises the north-western, western, and north Indian population whereas the southern Indian and eastern Indian population is caught in a loose cluster ([Figure 3](#f3){ref-type="fig"}). The controls were taken from published data defining Indian lineage for PCA and [Haplogroup Network](http://www.familytreedna.com/public/h%20mtdna%20haplogroup/default.aspx?section=goals). We have treated the patients as a sub group of individuals having genetic structure different from normal Indians e.g., population. The inferences from PCA plot strongly supports our motive behind the planning of experiment, interestingly the patient population has not shown any relevant genetic affinity with other macropopulations of India.

![PCA plot of keratoconus patients with Indian population.](mv-v17-1514-f3){#f3}

Discussion
==========

In this study we analyzed mitochondrial complex 1 gene in 20 keratoconus patients (negative for VSX1 mutations \[[@r13]\]) and 20 unrelated healthy controls. The cornea, being an avascular structure and the first in line of ultraviolet (UV) radiation, is very susceptible to UV induced oxidative damage. Previous studies \[[@r10],[@r11]\] suggested the role of oxidative stress in corneal disorders and congenital glaucoma \[[@r12]\]. Since the complex 1 NADH group of genes are most frequently associated with increased ROS production and oxidative stress \[[@r12],[@r24]\], in this pilot study we analyzed mitochondrial complex I gene for sequence variations. Most of the mutations were found in *ND5* (n=28) followed by *ND4* (15) and then *ND2* (13). The frequent variations in *ND5* are in accordance with previous reports that mutations in *ND5* gene of complex 1 play an important role in mitochondrial diseases \[[@r25]\].

In this study we report two novel frame shift mutations. Patient (KC 2) harbored a two base deletion (CA) which caused a frameshift and introduced a stop codon at position 287 in protein (normal ND2 protein is 347 amino acids long). The truncated protein cannot substitute the wild type ND2 protein as frameshift altered the reading frame of *ND2*. Sequence variations in this gene are associated with several diseases e.g., Leigh syndrome, breast cancer, myocardial infarction, Parkinson disease, and primary congenital glaucoma (PCG) \[[@r12],[@r26]-[@r29]\].

Patient (KC 16) harbored a single base deletion which resulted in a frame shift mutation after codon 172 (Gly\>Ala) and introduced a stop codon at position 174 in protein and produced a truncated protein of 173 amino acids (wild type ND4 protein is 459 amino acids long).

Studies have documented that G10398A is associated with elevated ROS production due to altered complex 1 function \[[@r29]-[@r32]\]. Role of this allele G10398A has been implicated in diseases like congenital glaucoma, Parkinson, Type-2 diabetes, and in pre-term births \[[@r12],[@r29]-[@r33]\]. The G10398A variation though associated with high ROS levels was present significantly higher in cases as compared to controls however this is present in 43% Indian population. The 4216T\>C variation considered as secondary or intermediate LHON-Leber's Hereditary optic neuropathy mutation was also present in 3 patients. However these patients had no features of LHON.

Evolutionary insight of Mt complex I sequence variations
--------------------------------------------------------

The genetic diversity in India is very complex. Several mutations from even control regions have been classified into the associative agent for various diseases \[[@r34]\]. The degree of haplotype sharing between populations is to investigate the combined frequency of the shared haplotypes in two population groups. Thus, among the northern and the southern population groups the combined frequency of the haplotypes present also in the other group is significantly lower than that which we observed in the case of random groups. This is not surprising because West Eurasian-specific mtDNA haplogroups are rather frequent in northwest India \[[@r35]\]. Because the Indo-European and the Dravidic speakers of India are largely concentrated to the northern and southern parts of the subcontinent, respectively, the differences arising from geographic division of the Indian populations also correspond to different linguistic groupings \[[@r36]\]. In this study, we found that all the mutations were apparently North-Indian specific with some novel mutations. The sequencing of Complex 1 revealed 84 mutations, of which 14, including 2 frame shift mutations and 4 non-synonymous mutations, were novel and exclusively observed in KC patients. Interestingly, most of the patients and their maternal relatives were clustered under the haplogroups (T, C4a2a, R2'TJ, M21'Q1a, M12'G2a2a, M8'CZ, M7a2a, U5b1, U1a3) which are present as negligible frequency in normal Indian population, whereas only few patients were found to be a part of the haplogroups whose origin is contentious i.e., U7 (Indo-European), R2 and R31. We have found three patients who fall under Indian haplogroups (M4, M4'63, R31a1) but they also carry the same sets of novel synonymous and non-synonymous mutations i.e., 4769, 4985, 5580, and 12850 ([Figure 4](#f4){ref-type="fig"}). We have found some novel mutations in addition to each individual's lineages and they are different from each other. This finding suggests the positive/causative role of different combinations of the mitochondrial coding mutations in this disease, as the normal population, completely lack these mutations.

![Network tree of the keratoconus patients and their comparison with other normal population.](mv-v17-1514-f4){#f4}

The patients harbored some novel mutations at the different sites in mitochondria i.e., 4769, 4985, 5580, and 12850. These variants have never been reported in any of the population studies whereas they were present in every patient. Nevertheless, it is impossible from the evolutionary point of view that these sets of mutations in the individuals from different haplogroup. By keeping in mind about mutation rates in the coding region and its natural selection \[[@r37]\], we propose that these variants could theoretically influence the patient's phenotype. However, the variants present in coding regions of mitochondrial gene are not conserved in course of evolution. The patients were apparently homoplasmic (only one type of mtDNA was present). To determine whether the maternal inherited gene pool of keratoconus patients is truly closer to any major populations in India, we have constructed the haplogroup frequency based PCA plot for mtDNA ([Figure 3](#f3){ref-type="fig"}). Indeed, this analysis shows ambiguously that the three Indian populations clusters tightly among themselves viz. North, North West and West populations and two populations are to be found in a loose cluster viz South Indian and East Indian, whereas the keratoconus population matches with none of them in the mtDNA PCA plots. However the genetic data indicates that the keratoconus patients comprise several different haplotypes, if they are compared to normal populations around them. Most of the patients are in the clades which are nonspecific to Indian lineages. This information suggests that keratoconus patients are among those who are recent migrants into India and some genes in mitochondria have acquired mutations which are not filtered by purifying selection. Our results explain that the patients are genetically unrelated to each other due to the present maternal lineages which were diversified in the history of evolution. This fact suggests that the polymorphisms which are playing pivotal roles in causing the disease are recently accumulated in the mitochondrial coding regions of an individual patient. We have found that mutations specifically found in KC patients can affect transcription, translation or have synergistic effect with other variants in causing the disease. It has been reported many times about synergistic effect of different mutations in mitochondria that can cause many severe diseases \[[@r38]\]. Nevertheless, it is impossible from the evolutionary point of view these sets of mutations to occur in the normal individual from different haplogroups. By keeping in mind about mutation rates in the coding region and its natural selection, we propose that these variants could theoretically influence the patient's disease. Non-synonymous mutations and frame shift mutations adversely affect C1 synergetics resulting in increase ROS production and mitochondrial dysfunction. KC corneas are unable to process ROS due to depleted or low ATP levels and increased ROS production and thereby undergo oxidative damage. These corneas have increased levels of malondialdehyde (MDA), which can results in altered protein function leading to cascade of events, including apoptosis that can damage the corneal tissues.

Thus this pilot study highlights the role of sequence variation in mitochondrial complex I gene in keratoconus patients. Such cases with elevated free radicals levels and oxidative damage to cornea may benefit immensely by antioxidant therapy.

Conclusions
-----------

Keratoconus corneas are known to suffer from oxidative damage. It is important to analyze the cause of raised ROS levels. Hence in this study we analyzed mitochondrial complex I genes, as sequence variations in this gene complex are associated with depleted ATP and increased ROS levels. We found a higher number of non-synonymous sequence variations in KC patients in comparison to controls.
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